Cargando…
Reply to the Letter to the editor “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”
Autores principales: | Takahashi, Hirokazu, Anzai, Keizo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426383/ https://www.ncbi.nlm.nih.gov/pubmed/35531591 http://dx.doi.org/10.1002/hep4.1996 |
Ejemplares similares
-
Reply to: “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”
por: van Kleef, Laurens A., et al.
Publicado: (2022) -
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD
por: Takahashi, Hirokazu, et al.
Publicado: (2021) -
Reply to letter to the editor
por: Kvasnovsky, Charlotte L., et al.
Publicado: (2020) -
Letter to the editor: Reply
por: Shim, Jung-Woo, et al.
Publicado: (2021) -
Authors’ reply to Hansel’s letter to the editor
por: Kotani, Yuki, et al.
Publicado: (2023)